These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26915450)

  • 1. Neurodegenerative disease: Immunotherapy opportunity emerges for Alzheimer disease.
    Crunkhorn S
    Nat Rev Drug Discov; 2016 Mar; 15(3):158. PubMed ID: 26915450
    [No Abstract]   [Full Text] [Related]  

  • 2. Alzheimer disease: Cancer immunotherapy drug reduces symptoms of Alzheimer disease in mice.
    Malkki H
    Nat Rev Neurol; 2016 Mar; 12(3):126. PubMed ID: 26823148
    [No Abstract]   [Full Text] [Related]  

  • 3. PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer's disease.
    Baruch K; Deczkowska A; Rosenzweig N; Tsitsou-Kampeli A; Sharif AM; Matcovitch-Natan O; Kertser A; David E; Amit I; Schwartz M
    Nat Med; 2016 Feb; 22(2):135-7. PubMed ID: 26779813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody against C-terminal Abeta selectively elevates plasma Abeta.
    Gray AJ; Sakaguchi G; Shiratori C; Becker AG; LaFrancois J; Aisen PS; Duff K; Matsuoka Y
    Neuroreport; 2007 Feb; 18(3):293-6. PubMed ID: 17314674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic immune-checkpoint blockade with anti-PD1 antibodies does not alter cerebral amyloid-β burden in several amyloid transgenic mouse models.
    Latta-Mahieu M; Elmer B; Bretteville A; Wang Y; Lopez-Grancha M; Goniot P; Moindrot N; Ferrari P; Blanc V; Schussler N; Brault E; Roudières V; Blanchard V; Yang ZY; Barneoud P; Bertrand P; Roucourt B; Carmans S; Bottelbergs A; Mertens L; Wintmolders C; Larsen P; Hersley C; McGathey T; Racke MM; Liu L; Lu J; O'Neill MJ; Riddell DR; Ebneth A; Nabel GJ; Pradier L
    Glia; 2018 Mar; 66(3):492-504. PubMed ID: 29134678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alzheimer disease and immunotherapy: hope or disillusion?].
    Dubois B
    Encephale; 2006 Sep; 32 Pt 5():S638-40. PubMed ID: 17099588
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanisms of A beta plaque clearance following passive A beta immunization.
    Morgan D
    Neurodegener Dis; 2005; 2(5):261-6. PubMed ID: 16909007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.
    Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA
    J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of blood-brain barrier in the pathogenesis of Alzheimer dementia--implications for immunological therapies for plaque dissolution].
    Pahnke J; Krohn M; Scheffler K
    Fortschr Neurol Psychiatr; 2009 Aug; 77 Suppl 1():S21-4. PubMed ID: 19685385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current trend of immunotherapy for Alzheimer's disease].
    Matsumoto SE; Tabira T
    Nihon Rinsho; 2011 Sep; 69(9):1628-32. PubMed ID: 21922765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comment on Vandal et al. Insulin Reverses the High-Fat Diet-Induced Increase in Brain Aβ and Improves Memory in an Animal Model of Alzheimer Disease. Diabetes 2014;63:4291-4301.
    Ghanim H; Dandona P
    Diabetes; 2015 Jul; 64(7):e17. PubMed ID: 26106201
    [No Abstract]   [Full Text] [Related]  

  • 12. Response to Comment on Vandal et al. Insulin Reverses the High-Fat Diet-Induced Increase in Brain Aβ and Improves Memory in an Animal Model of Alzheimer Disease. Diabetes 2014;63:4291-4301.
    Vandal M; Calon F
    Diabetes; 2015 Jul; 64(7):e18. PubMed ID: 26106202
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunological approaches for amyloid-beta clearance toward treatment for Alzheimer's disease.
    Solomon B
    Rejuvenation Res; 2008 Apr; 11(2):349-57. PubMed ID: 18341423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined treatment of amyloid-β₁₋₄₂-stimulated bone marrow-derived dendritic cells plus splenocytes from young mice prevents the development of Alzheimer's disease in APPswe/PSENldE9 mice.
    Wang F; Liu H; Shen X; Ao H; Moore N; Gao L; Chen L; Hu H; Ma H; Yang Z; Zhai C; Qin J; Zhou G; Peng Y; Feng X; Li R; Liang C
    Neurobiol Aging; 2015 Jan; 36(1):111-22. PubMed ID: 25085784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical observations with AN-1792 using TAPIR analyses.
    Hock C; Nitsch RM
    Neurodegener Dis; 2005; 2(5):273-6. PubMed ID: 16909009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tau passive immunization inhibits not only tau but also Aβ pathology.
    Dai CL; Tung YC; Liu F; Gong CX; Iqbal K
    Alzheimers Res Ther; 2017 Jan; 9(1):1. PubMed ID: 28073379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved Brain Expression of Anti-Amyloid β scFv by Complexation of mRNA Including a Secretion Sequence with PEG-based Block Catiomer.
    Perche F; Uchida S; Akiba H; Lin CY; Ikegami M; Dirisala A; Nakashima T; Itaka K; Tsumoto K; Kataoka K
    Curr Alzheimer Res; 2017; 14(3):295-302. PubMed ID: 27829339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active immunotherapy facilitates Aβ plaque removal following through microglial activation without obvious T cells infiltrating the CNS.
    Sha S; Xing XN; Cao YP
    J Neuroimmunol; 2014 Sep; 274(1-2):62-70. PubMed ID: 25087756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutated tau, amyloid and neuroinflammation in Alzheimer disease-A brief review.
    Hung AS; Liang Y; Chow TC; Tang HC; Wu SL; Wai MS; Yew DT
    Prog Histochem Cytochem; 2016 May; 51(1):1-8. PubMed ID: 26851150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nootropic and neuroprotective proline-containing dipeptide noopept restores spatial memory and increases immunoreactivity to amyloid in an Alzheimer's disease model.
    Ostrovskaya RU; Gruden MA; Bobkova NA; Sewell RD; Gudasheva TA; Samokhin AN; Seredinin SB; Noppe W; Sherstnev VV; Morozova-Roche LA
    J Psychopharmacol; 2007 Aug; 21(6):611-9. PubMed ID: 17092975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.